Dual-functional Brij-S20-modified nanocrystal formulation enhances the intestinal transport and oral bioavailability of berberine

References

• ChavdaHVPatelCNAnandISBiopharmaceutics classification systemSys Rev Pharm2010116269
   Google Scholar
• Al-KassasRBansalMShawJNanosizing techniques for improving bioavailability of drugsJ Control Release201726020221228603030
   PubMed Web of Science ®Google Scholar
• GökeKLorenzTRepanasANovel strategies for the formulation and processing of poorly water-soluble drugsEur J Pharm Biopharm2018126405628532676
   PubMed Web of Science ®Google Scholar
• JermainSVBroughCWilliamsROAmorphous solid dispersions and nanocrystal technologies for poorly water-soluble drug delivery – an updateInt J Pharm2018535137939229128423
   PubMed Web of Science ®Google Scholar
• LoftssonTDrug solubilization by complexationInt J Pharm2017531127628028842309
   PubMedGoogle Scholar
• SinghBBegSKhuranaRKSandhuPSKaurRKatareOPRecent advances in self-emulsifying drug delivery systems (SEDDS)Crit Rev Ther Drug Carrier Syst201431212118524940626
   PubMed Web of Science ®Google Scholar
• ZhangLWangSZhangMSunJNanocarriers for oral drug deliveryJ Drug Target201321651552723621127
   PubMed Web of Science ®Google Scholar
• PathakKRaghuvanshiSOral bioavailability: issues and solutions via nanoformulationsClin Pharmacokinet201554432535725666353
   PubMed Web of Science ®Google Scholar
• GaoLLiuGMaJApplication of drug nanocrystal technologies on oral drug delivery of poorly soluble drugsPharm Res201330230732423073665
   PubMed Web of Science ®Google Scholar
• Zakeri-MilaniPValizadehHIntestinal transporters: enhanced absorption through P-glycoprotein-related drug interactionsExpert Opin Drug Metab Toxicol201410685987124708201
   PubMed Web of Science ®Google Scholar
• AnkitSRavindra DharDNoorAVaibhavKPremNGCo-formulation of P-glycoprotein substrate and inhibitor in nanocarriers: an emerging strategy for cancer chemotherapyCurr Cancer Drug Targets201414541943324720364
   PubMed Web of Science ®Google Scholar
• AlakhovaDYKabanovAVPluronics and MDR reversal: an updateMol Pharm20141182566257824950236
   PubMed Web of Science ®Google Scholar
• AyatiSHFazeliBMomtazi-BorojeniAACiceroAFGPirroMSahebkarARegulatory effects of berberine on microRNome in cancer and other conditionsCrit Rev Oncol Hematol201711614715828693796
   PubMed Web of Science ®Google Scholar
• RabbaniGHButlerTKnightJSanyalSCAlamKRandomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio choleraeJ Infect Dis198715559799843549923
   PubMed Web of Science ®Google Scholar
• ChenCTaoCLiuZA randomized clinical trial of berberine hydrochloride in patients with diarrhea-predominant irritable bowel syndromePhytother Res201529111822182726400188
   PubMed Web of Science ®Google Scholar
• ČerňákováMKošťálováDAntimicrobial activity of berberine – a constituent of Mahonia aquifoliumFolia Microbiol (Praha)200247437537812422513
   PubMed Web of Science ®Google Scholar
• KaraosmanogluKSayarNAKurnazIAAkbulutBSAkbulutBSAssessment of berberine as a multi-target antimicrobial: a multiomics study for drug discovery and repositioningOmics2014181425324237354
   PubMed Web of Science ®Google Scholar
• CiceroAFGBaggioniABerberine and its role in chronic diseaseGuptaSCPrasadSAggarwalBBAnti-Inflammatory Nutraceuticals and Chronic DiseasesCham, SwitzerlandSpringer, International Publishing20162745
   Google Scholar
• PangBZhaoL-HZhouQApplication of berberine on treating type 2 diabetes mellitusInt J Endocrinol2015201590574925861268
   PubMed Web of Science ®Google Scholar
• ChangWNon-coding RNAs and berberine: a new mechanism of its anti-diabetic activitiesEur J Pharmacol201779581227915042
   PubMed Web of Science ®Google Scholar
• PirilloACatapanoALBerberine, a plant alkaloid with lipid- and glucose-lowering properties: from in vitro evidence to clinical studiesAtherosclerosis2015243244946126520899
   PubMed Web of Science ®Google Scholar
• JiangWLiSLiXTherapeutic potential of berberine against neuro-degenerative diseasesSci China Life Sci201558656456925749423
   PubMed Web of Science ®Google Scholar
• AhmedTGilaniA-U-HAbdollahiMDagliaMNabaviSFNabaviSMBerberine and neurodegeneration: a review of literaturePharmacol Rep201567597097926398393
   PubMed Web of Science ®Google Scholar
• LiZGengY-NJiangJ-DKongW-JAntioxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitusEvid Based Complement Alternat Med2014201428926424669227
   PubMed Web of Science ®Google Scholar
• NiW-JDingH-HTangL-QBerberine as a promising anti-diabetic nephropathy drug: an analysis of its effects and mechanismsEur J Pharmacol201576010311225912800
   PubMed Web of Science ®Google Scholar
• HabtemariamSBerberine and inflammatory bowel disease: a concise reviewPharmacol Res2016113Pt A59259927697643
   PubMedGoogle Scholar
• Guamán OrtizMLLombardiPTillhonMScovassiIABerberine, an epiphany against cancerMolecules2014198123491236725153862
   PubMed Web of Science ®Google Scholar
• WangNTanH-YLiLYuenM-FFengYBerberine and coptidis rhizoma as potential anticancer agents: recent updates and future perspectivesJ Ethnopharmacol2015176354826494507
   PubMed Web of Science ®Google Scholar
• ZouKLiZZhangYAdvances in the study of berberine and its derivatives: a focus on anti-inflammatory and anti-tumor effects in the digestive systemActa Pharmacol Sin201738215716727917872
   PubMed Web of Science ®Google Scholar
• ShenRKimJJYaoMElbayoumiTADevelopment and evaluation of vitamin E d-α-tocopheryl polyethylene glycol 1000 succinate-mixed polymeric phospholipid micelles of berberine as an anticancer nanopharmaceuticalInt J Nanomedicine2016111687170027217747
   PubMed Web of Science ®Google Scholar
• ZhaojieMMingZShengnanWAmorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailabilityInt J Pharm20144671505924607213
   PubMed Web of Science ®Google Scholar
• TsaiP-LTsaiT-HHepatobiliary excretion of berberineDrug Metab Dispos200432440515039293
   PubMed Web of Science ®Google Scholar
• ZhangXQiuFJiangJGaoCTanYIntestinal absorption mechanisms of berberine, palmatine, jateorhizine, and coptisine: involvement of P-glycoproteinXenobiotica201141429029621319959
   PubMed Web of Science ®Google Scholar
• ShiJGuoFZhengAZhangXSunJProgress in the study of drug nanocrystalsDie Pharmazie2015701275776426817271
   PubMed Web of Science ®Google Scholar
• RabinowBENanosuspensions in drug deliveryNat Rev Drug Discov20043978579615340388
   PubMed Web of Science ®Google Scholar
• NagarwalRCKumarRDhanawatMDasNPanditJKNanocrystal technology in the delivery of poorly soluble drugs: an overviewCurr Drug Deliv20118439840621453258
   PubMed Web of Science ®Google Scholar
• KhajuriaDKKonnurMCVasireddiRMahapatraDRPhotonic monitoring of chitosan nanostructured alginate microcapsules for drug releaseProceedings of SPIE 9303, Photonic Therapeutics and Diagnostics XI93033VSan Francisco, CAFebruary 26, 2015
   Google Scholar
• GaoLLiuGKangJPaclitaxel nanosuspensions coated with P-gp inhibitory surfactants: I. Acute toxicity and pharmacokinetics studiesColloids Surf B Biointerfaces201311127728123838193
   PubMed Web of Science ®Google Scholar
• PatelKPatilAMehtaMGotaVVaviaPOral delivery of paclitaxel nanocrystal (PNC) with a dual Pgp-CYP3A4 inhibitor: preparation, characterization and antitumor activityInt J Pharm2014472121422324954663
   PubMedGoogle Scholar
• RibeiroMde MouraCLVieiraMGSSolubilisation capacity of Brij surfactantsInt J Pharm2012436163163522842626
   PubMedGoogle Scholar
• TangJWangYWangDKey structure of Brij for overcoming multidrug resistance in cancerBiomacromolecules201314242443023311629
   PubMed Web of Science ®Google Scholar
• YuHHuYQIpFCFZuoZHanYFIpNYIntestinal transport of bis(12)-hupyridone in Caco-2 cells and its improved permeability by the surfactant Brij-35Biopharm Drug Dispos201132314015021271607
   PubMed Web of Science ®Google Scholar
• CuiHMZhangQYWangJLChenJLZhangYLTongXLPoor permeability and absorption affect the activity of four alkaloids from coptisMol Med Rep20151257160716826352530
   PubMed Web of Science ®Google Scholar
• JinDZhaoTFengW-WSchisandra polysaccharide increased glucose consumption by up-regulating the expression of GLUT-4Int J Biol Macromol20168755556226993529
   PubMed Web of Science ®Google Scholar
• LiuFParkJYZhangYTargeted cancer therapy with novel high drug-loading nanocrystalsJ Pharm Sci20109983542355120564383
   PubMed Web of Science ®Google Scholar
• XiongWLiLWangYDesign and evaluation of a novel potential carrier for a hydrophilic antitumor drug: auricularia auricular polysaccharide-chitosan nanoparticles as a delivery system for doxorubicin hydrochlorideInt J Pharm2016511126727527424168
   PubMedGoogle Scholar
• XiongWZhangQYinFAuricularia auricular polysaccharide-low molecular weight chitosan polyelectrolyte complex nanoparticles: preparation and characterizationAsian J Pharm Sci2016113439448
   Web of Science ®Google Scholar
• GuoYChuMTanSChitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistanceMol Pharm2014111597024229050
   PubMedGoogle Scholar
• ShiCTongQFangJWangCWuJWangWPreparation, characterization and in vivo studies of amorphous solid dispersion of berberine with hydrogenated phosphatidylcholineEur J Pharm Sci201574Suppl C111725861719
   PubMedGoogle Scholar
• ZhangZChenYDengJJiaXZhouJLvHSolid dispersion of berberine–phospholipid complex/TPGS 1000/SiO2: preparation, characterization and in vivo studiesInt J Pharm2014465130631624456672
   PubMedGoogle Scholar
• ChenC-JChinJEUedaKInternal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cellsCell19864733813892876781
   PubMed Web of Science ®Google Scholar
• DidierAWengerJLoorFDecreased uptake of cyclosporin A by P-glycoprotein (Pgp) expressing CEM leukemic cells and restoration of normal retention by Pgp blockersAnticancer drugs1995656696808845477
   PubMed Web of Science ®Google Scholar
• FojoATUedaKSlamonDJPoplackDGGottesmanMMPastanIExpression of a multidrug-resistance gene in human tumors and tissuesProc Natl Acad Sci U S A19878412652692432605
   PubMed Web of Science ®Google Scholar
• ZhangZTanSFengS-SVitamin E TPGS as a molecular biomaterial for drug deliveryBiomaterials201233194889490622498300
   PubMed Web of Science ®Google Scholar
• SilvaRVilasboasVCarmoHModulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategyPharmacol Ther20151492112325435018
   PubMedGoogle Scholar
• RobeyRWZhanZPiekarzRLKayasthaGLFojoTBatesSEIncreased MDR1 expression in normal and malignant peripheral blood mononuclear cells obtained from patients receiving depsipeptide (FR901228, FK228, NSC630176)Clin Cancer Res20061251547155516533780
   PubMed Web of Science ®Google Scholar
• HaslamISJonesKColemanTSimmonsNLInduction of P-glycoprotein expression and function in human intestinal epithelial cells (T84)Biochem Pharmacol200876785086118703021
   PubMed Web of Science ®Google Scholar
• AriasARigalliJPVillanuevaSSRegulation of expression and activity of multidrug resistance proteins MRP2 and MDR1 by estrogenic compounds in Caco-2 cells. Role in prevention of xenobiotic-induced cytotoxicityToxicology2014320465524685904
   PubMed Web of Science ®Google Scholar
• AmbudkarSVDeySHrycynaCARamachandraMPastanIGottesmanMMBiochemical, cellular, and pharmacological aspects of the multidrug transporterAnnu Rev Pharmacol Toxicol199939136139810331089
   PubMed Web of Science ®Google Scholar
• ChanKFZhaoYBurkettBAWongILKChowLMCChanTHFlavonoid dimers as bivalent modulators for P-glycoprotein-based multidrug resistance: synthetic apigenin homodimers linked with defined-length poly(ethylene glycol) spacers increase drug retention and enhance chemosensitivity in resistant cancer cellsJ Med Chem200649236742675917154505
   PubMed Web of Science ®Google Scholar
• KimMKChooHChongYWater-soluble and cleavable quercetin–amino acid conjugates as safe modulators for P-glycoprotein-based multidrug resistanceJ Med Chem201457177216723325122155
   PubMed Web of Science ®Google Scholar
• FontePReisSSarmentoBFacts and evidences on the lyophilization of polymeric nanoparticles for drug deliveryJ Control Release2016225758626805517
   PubMed Web of Science ®Google Scholar
• MoulySPaineMFP-Glycoprotein increases from proximal to distal regions of human small intestinePharm Res200320101595159914620513
   PubMed Web of Science ®Google Scholar
• ChenCLiuXSmithBJUtility of Mdr1-gene deficient mice in assessing the impact of P-glycoprotein on pharmacokinetics and pharmacodynamics in drug discovery and developmentCurr Drug Metab20034427229112871045
   PubMed Web of Science ®Google Scholar